Drreddys Laboratories | Ativo Circulante



Current Assets Alterar Data
ANI Pharmaceuticals USD 527.68M 6.39M 2024-12
Aurora Cannabis CAD 494.21M 76.54M 2024-12
Bayer EUR 34.44B 1.31B 2024-12
Canopy Growth CAD 341.08M 50.58M 2024-12
Cipla INR 209.45B 15.04B 2024-09
Corcept Therapeutics USD 471.6M 4.62M 2024-12
Drreddys Laboratories INR 253.02B 4.89B 2024-12
GlaxoSmithKline GBP 18.08B 1.09B 2025-03
Hikma Pharmaceutical USD 2.28B 185M 2024-06
Lonza CHF 5.44B 113M 2024-12
Novartis USD 29.7B 1.56B 2024-12
Pacira USD 745.13M 55.16M 2024-12
Prestige Brands USD 377.16M 3.54M 2024-12
Richter Gedeon HUF 641.06B 69.19B 2024-12
Sun Pharmaceuticals INR 461.05B 26.3B 2024-09
Supernus Pharmaceuticals USD 686.07M 46.07M 2024-12
Teva Pharmaceutical Industries USD 12.55B 238M 2024-12



Drreddys Laboratories Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.